DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

BLACKROSE vs SUDARSHAN: Stock Comparison

BLACK ROSE INDS. vs SUDARSHAN PHARMA INDUpdated 13 Nov 26, 4:08 PM ISTNSE & company filings

BLACK ROSE INDS. shows a lower P/E, a higher dividend yield and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BLACKROSE leads 5; SUDARSHAN leads 2 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BLACKROSESUDARSHAN

Valuation lens

What price are you paying?

Market CapContext only
₹513 Cr
₹0 Cr
P/E RatioBLACKROSE has the lower reading
17.79x ✓
28.27x
P/B RatioBLACKROSE has the lower reading
3.01x ✓
4.11x
EPSBLACKROSE has the higher reading
₹2.06 ✓
₹0.32
Book ValueContext only
₹33.22
₹6.14
Dividend YieldBLACKROSE has the higher reading
3.23% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
BLACKROSE has a lower P/E
17.79x vs 28.27x
P/B Ratio
BLACKROSE has a lower P/B
3.01x vs 4.11x
EPS
BLACKROSE has higher earnings per share
₹2.06 vs ₹0.32
Dividend Yield
BLACKROSE has a higher dividend yield
3.23% vs 0%
Qtr Sales Growth
SUDARSHAN has stronger quarterly sales growth
24.4% vs -1.57%
Qtr Profit Growth
SUDARSHAN has stronger quarterly profit growth
38.7% vs 0.78%
Net Margin
BLACKROSE has a higher net margin
6.96% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricBLACKROSESUDARSHAN
Live Price₹100.42₹32.71
Day Change1.2%0.03%
Volume24,59692,985
52-Week High₹129.9₹39.3
52-Week Low₹80.05₹31.01
Distance from 52W High-22.69%-16.77%

Valuation

MetricBLACKROSESUDARSHAN
Market Cap₹513 Cr₹0 Cr
P/E Ratio17.79x28.27x
P/B Ratio3.01x4.11x
EPS₹2.06₹0.32
Book Value₹33.22₹6.14
Dividend Yield3.23%0%

Growth

MetricBLACKROSESUDARSHAN
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-1.57%24.4%
Qtr Profit Growth0.78%38.7%

Profitability & Leverage

MetricBLACKROSESUDARSHAN
ROE13.26%—
ROCE14.52%—
Net Margin6.96%0%
Operating Margin9.76%—
Debt to Equity0x—

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBLACKROSESUDARSHAN
Promoter Holding0.47%57.81%▼ 1.12 pp
FII Holding0%21.95%▲ 2.57 pp
DII Holding0.18%▲ 0.03 pp0%
Public Holding24.82%▼ 0.03 pp20.19%▼ 1.45 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BLACK ROSE INDS. and SUDARSHAN PHARMA IND.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.